DSGN Insider Trading Activity and SEC Form 4 Filings
DSGN insider trading summary
No open-market insider purchases or sales of Design Therapeutics, Inc. (DSGN) have been reported on SEC Form 4 in the past 12 months.
Latest DSGN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 13, 2025 | Arsani William | Insider | Sell | $1.8M (345,000 @ $5.25) |
| Aug 13, 2025 | Arsani William | Insider | Sell | $1.1M (217,627 @ $5.25) |
| Dec 18, 2024 | Deepa Prasad | Insider | Sell | $24K (3,806 @ $6.27) |
| Aug 9, 2024 | Arsani William | Insider | Sell | $3.5M (814,874 @ $4.25) |
| Mar 25, 2024 | Heather A. Berger | Insider | Buy | $5K (1,300 @ $3.74) |
| Mar 25, 2024 | John P. Schmid | Insider | Buy | $67K (17,809 @ $3.74) |
| Mar 22, 2024 | John P. Schmid | Insider | Buy | $33K (9,156 @ $3.62) |
| Sep 29, 2023 | Rodney W Lappe | Director | Buy | $49K (21,000 @ $2.35) |
| Aug 29, 2023 | Arsani William | Director | Buy | $4.8M (1,960,000 @ $2.44) |
| Aug 29, 2023 | Deepa Prasad | Director | Buy | $28K (12,000 @ $2.31) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.